Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania.
Brown, J; BAISLEY, K; Kavishe, B; Changalucha, J; Andreasen, A; MAYAUD, P; Gumodoka, B; KAPIGA, S; HAYES, R; WATSON-JONES, D;
2013
Vaccine, (2013).32 5 10.1016/j.vaccine.2013.11.061.
Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine.
Brueggemann, AB; Muroki, BM; Kulohoma, BW; Karani, A; Wanjiru, E; Morpeth, S; Kamau, T; Sharif, S; SCOTT, JA G;
2013
PloS one, (2013).8 11 10.1371/journal.pone.0081539.
Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data.
JACKSON, C; MANN, A; MANGTANI, P; FINE, P;
2013
The Pediatric infectious disease journal, (2013).32 11 10.1097/INF.0b013e3182a14e57.
Factors Associated with In Vitro Immune Response to Mycobacterial and Tetanus Antigens Following BCG and Tetanus Immunisation in Infancy.
Lule, SA; Gyavira, N; Muhangi, L; Kizito, D; ELLIOTT, A; WEBB, E;
2013
AIDS research and human retroviruses, (2013).29 11
Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
Breteler, JK; Tam, JS; JIT, M; Ket, JC F; De Boer, MR;
2013
Vaccine, (2013).31 45 10.1016/j.vaccine.2013.08.056.
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
FLETCHER, HA; Tanner, R; Wallis, RS; Meyer, J; Manjaly, Z-R; Harris, S; Satti, I; Silver, RF; Hoft, D; KAMPMANN, B; Walker, KB; DOCKRELL, HM; Fruth, U; Barker, L; Brennan, MJ; McShane, H;
2013
Clinical and vaccine immunology, (2013).20 11 10.1128/CVI.00427-13.
Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
Ridenhour, BJ; Campitelli, MA; Kwong, JC; Rosella, LC; ARMSTRONG, BG; MANGTANI, P; Calzavara, AJ; Shay, DK;
2013
PloS one, (2013).8 10 10.1371/journal.pone.0076318.
The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.
FLASCHE, S; EDMUNDS, WJ; MILLER, E; Goldblatt, D; Robertson, C; Choi, YH;
2013
Proceedings Biological sciences / The Royal Society, (2013).280 1771 10.1098/rspb.2013.1939.
Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.
BAGUELIN, M; FLASCHE, S; CAMACHO, A; Demiris, N; MILLER, E; EDMUNDS, WJ;
2013
PLoS medicine, (2013).10 10 10.1371/journal.pmed.1001527.
Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial.
ROCA, A; Dione, MM; BOJANG, A; Townend, J; Egere, U; Darboe, O; Howie, SR C; Hill, PC; Adegbola, RA; GREENWOOD, BM; ANTONIO, M;
2013
PLOS ONE, (2013).8 9 10.1371/journal.pone.0072198.